HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Poirier, M.-B. Articles by Langlois, M.-F. Search for Related Content PubMed PubMed Citation Articles by Poirier, M.-B. Articles by Langlois, M.-F.

Department of Medicine and Physiology, Division of Endocrinology, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, C.H.U.S. 3001, 12th Avenue North, Sherbrooke, Quebec, Canada J1H 5N4

(Requests for offprints should be addressed to M-F Langlois; Email: Marie-France.Langlois{at}USherbrooke.ca)

Thyroid hormone receptors (TRs) are transcription factor members of the nuclear receptor superfamily. The transcriptional activity of TRs is controlled by thyroid hormones and cell-specific coregulators. Using the yeast two-hybrid system, we identified RanBPM as a new protein partner for TRs. RanBPM was initially discovered as an interacting partner for Ran, and was also shown to be a protein partner and coactivator of the androgen receptor. The novel interaction between RanBPM and TR isoforms was addressed by glutathione-S-transferase (GST) pull-down assays and co-immunoprecipitation in intact mammalian cells, where RanBPM was shown to bind TRs in a ligand-independent fashion. We also studied the regions implicated in the interaction with deletion mutants: the principal interacting region of RanBPM is comprised within its carboxyl-terminal end and the TR DNA-binding domain is sufficient to mediate the interaction. To investigate the potential role of RanBPM in thyroid hormone action, transient transfections with luciferase reporter genes were performed in CV-1 cells. We found that the over-expression of RanBPM increases the activation of TRETK- and DR+4-positive thyroid hormone response elements. Interestingly, over-expression of the truncated protein RanBPM55, which lacks the N-terminal polyglutaminated region but binds TRs, decreased the fold activation by almost 80%. Furthermore, we performed competition assays using transient transfection of RanBPM and increasing amounts of RanBPM55. This revealed that the stimulating effect on TR transactivation by the full-length protein is inhibited in a dose-dependent fashion by RanBPM55. This suggests that although the polyglutaminated region of RanBPM is not required for the binding to TRs, it is required for the stimulation of TR transactivation. Taken together, our results provide evidence that RanBPM is a potent novel coactivator for thyroid hormone receptors.

This article has been cited by other articles:

				X. Gong, W. Ye, H. Zhou, X. Ren, Z. Li, W. Zhou, J. Wu, Y. Gong, Q. Ouyang, X. Zhao, et al. RanBPM is an acetylcholinesterase-interacting protein that translocates into the nucleus during apoptosis Acta Biochim Biophys Sin, November 1, 2009; 41(11): 883 - 891. [Abstract] [Full Text] [PDF]